Author Title [ Type(Desc)] Year
Filters: Author is Barraco, Fiorenza  [Clear All Filters]
Journal Article
Michallet M, Sobh M, Serrier C, Morisset S, Labussière H, Ducastelle S, Barraco F, Gilis L, Thomas X, Nicolini FE. Allogeneic hematopoietic stem cell transplantation for hematological malignancies from mismatched 9/10 HLA unrelated donors: Comparison with transplantations from 10/10 unrelated donors and HLA identical siblings. Leuk Lymphoma. 2014:1-16.
Conrad A, Perry M, Langlois M-E, Labussière-Wallet H, Barraco F, Ducastelle-Lepretre S, Larcher M-V, Balsat M, Boccard M, Chidiac C, et al. Efficacy and safety of revaccination against tetanus, diphtheria, Haemophilus influenzae type b and hepatitis B virus in a prospective cohort of adult recipients of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2020.
Plesa A, Roumier C, Gutrin J, Larcher M-V, Balsat M, Cadassou O, Barraco F, Fossard G, Baudouin A, Labussière H, et al. Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. Leuk Res. 2021;111:106673.
Michallet M, Sobh M, Labussière H, Lombard C, Barraco F, El-Hamri M, Thomas X, Chapuis-Cellier C, Nicolini FE. Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Leuk Lymphoma. 2016:1-4.
Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, Quesnel B, Heiblig M, Sujobert P, Barraco F, et al. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a two center experience. Blood Adv. 2021.